key: cord-0511345-8c3r297l authors: Srivastava, Ambrish Kumar; Kumar, Abhishek; Misra, Neeraj title: On the Inhibition of COVID-19 Protease by Indian Herbal Plants: An In Silico Investigation date: 2020-04-05 journal: nan DOI: nan sha: 853bf23d1a7f460dad20a5128d21e236a45e6861 doc_id: 511345 cord_uid: 8c3r297l COVID-19 has quickly spread across the globe, becoming a pandemic. This disease has a variable impact in different countries depending on their cultural norms, mitigation efforts and health infrastructure. In India, a majority of people rely upon traditional Indian medicine to treat human maladies due to less-cost, easier availability and without any side-effect. These medicines are made by herbal plants. This study aims to assess the Indian herbal plants in the pursuit of potential COVID-19 inhibitors using in silico approaches. We have considered 18 extracted compounds of 11 different species of these plants. Our calculated lipophilicity, aqueous solubility and binding affinity of the extracted compounds suggest that the inhibition potentials in the order; harsingar>aloe vera>giloy>turmeric>neem>ashwagandha>red onion>tulsi>cannabis>black pepper. On comparing the binding affinity with hydroxychloroquine, we note that the inhibition potentials of the extracts of harsingar, aloe vera and giloy are very promising. Therefore, we believe that these findings will open further possibilities and accelerate the works towards finding an antidote for this malady. The coronavirus disease has been declared as a worldwide epidemic by the world health organization (WHO). According to the latest update of the WHO 1 , there are more than 1 million cases of the COVID-19 worldwide, causing almost 50 thousand deaths affecting 203 countries, areas or territories. This novel coronavirus was detected in late December 2019 and recognized in early January 2020 in China 2,3 . On 11 February 2020, the international committee on taxonomy of viruses declared this "severe acute respiratory syndrome coronavirus Unfortunately, there has been no noticeable breakthrough in the management of this disease to date and the patient is given a treatment based on his observable and diagnosable symptoms. Although several attempts have been made in the research and development of the diagnostics, therapeutics and vaccines for this novel coronavirus 7 , there exists no chemotherapeutic agent so far which has been shown unequivocally to be effective in treating human diseases due to a minuscule virus. To combat this deadly COVID-19, a number of conventional drugs 8-10 like chloroquine, hydroxychloroquine, remdesivir, etc. have been tried and found with certain curative effect in vitro. However, the clinical drug response is not very encouraging and toxicity remains an inevitable issue causing serious adverse effects 11 . This prompted us to study the inhibition of COVID-19 protease by Indian herbal plants. Because of the inherent side effects of the synthetic chemicals used in allopathic drugs, a sizeable population has switched over to the traditional system of medicine (herbal medicine) for their primary health care. Ayurveda, the age-old Indian system of medicine, is increasingly becoming a sought after system to bank on. The ayurvedic treatment has become an alternative to conventional medicines due to several reasons including easy availability, less or no side effects and less cost. India has always been a rich reservoir of medicinal plants because of several agro-climatic zones. Therefore, in the present work, we have chosen a multitude of and giloy are particularly interesting. Therefore, we believe that this study should offer some insights into the development of alternative drugs for this novel coronavirus. This study was performed by the SwissDock web server 15, 16 , which incorporates an automated in silico molecular docking procedure based on the EADock ESS docking algorithm. To determine the inhibition properties of Indian medicinal plants against COVID-19 protease, the potential target protein was retrieved from the RCSB protein data bank (PDB ID: 6LU7) deposited in February 2020 17 . The processed coordinates files for the ligands as well as COVID-19 protease (6LU7) has been uploaded, and docking was carried out with the "Accurate" parameter option, which is considered to be the most extensive for the sampling of the binding modes. The output clusters have been obtained after each docking runs and classified based on the full fitness (FF) score by the SwissDock algorithm. A greater negative FF score suggests a more favorable binding mode between ligand and receptor with a better fit. The visual graphics of docking results have been generated by using the UCSF Chimera program 18 . In addition, we have calculated the lipophilicity (log P) and aqueous solubility (log S) using ALOGPS 2.1 program 19 , which is based on the electro-topological state indices and associative neural network modeling 20 . These two parameters are very important for quantitative structure-property relationship (QSPR) studies. We have considered a total of 11 different varieties (species) of Indian medicinal plants. Godavari and also found in Indian gardens as ornamental plant. Giloy (moonseed plant or guduchi) is a large deciduous, extensively spreading climbing shrub found throughout India and also in Bangladesh, Srilanka and China. Aloe vera (ghrit kumari) is a well known medicinal plant with sharp pointed, lanced shaped and edged leaves having its origin in African content, Turmeric (circumin or haldi), a traditional Chinese medicine, is commonly used species in Indian subcontinent, not only for health but also for the preservation of food. Ashwagandha is known as Indian winter cherry. Neem (margosa tree) also called as Indian lilac with its centre of origin in southern and southeastern Asia, is regarded as "village dispensary" in India and also a religious gift from nature. Red onion is a versatile vegetable, i.e., consumed fresh as well as in the form of processed products. Tulsi is the one of the most religious and medicinal plant in India and grown throughout the country from Andaman and Nicobar island to the Himalayas. Cannabis is a plant of psychoactive drug and black pepper is a kind of household species used in India. In order to compare the biological activity and pharmacological behavior of the extracted compounds, we have evaluated their log P as well as log S values and listed in Table 1 . Log P measures the hydrophilicity of a compound. The compounds having high log P values show poor absorption or low permeability. One can note that the log P values of most of these compounds lie in the range 2.64-4.95. These values indicate that the compounds can easily diffuse across the cell membranes due to their high organic (lipid) permeability. However, lupeol, sitosterol, ursolic acid and cannabidiol have log P in the range 5.12-7.27 (exceeding to 5) and therefore, they possess high hydrophobicity and poor absorption. On the contrary, nictoflorin, astragalin, aloenin, aloesin and quercetin possess high absorption due to their log P in the range 0.05-1.81. Log S represents the aqueous solubility of the compound. It is an important factor, associated with the bioavailability of compounds. Most of these compounds have log S values higher than -5, except lupeol, sitosterol and ursolic acid. Note that the log S values of more than 85% of compounds (drugs) fall in the range between -1 and -5 21 . This is consistent with their log P values as poor solubility implies poor absorption and hence, bioavailability. Thus, log P along with log S values of these compounds confirmed their permeability across cell membranes. In particular, the nictoflorin, astragalin, aloenin, aloesin and quercetin seem to be more biologically potent. These parameters are also associated with their interaction with receptors. The molecular docking studies explore the interaction mechanism between ligands and receptors. The interactions between a ligand and receptor play a crucial role in the field of drug discovery. The molecular docking calculations have been performed as blind, i.e., covered the entire protein surface, not any specific region of the protein as the binding pocket in order to avoid sampling bias. The docking parameters such as binding affinity, FF score, and H-bond, bond-length along with amino acids (residue) found in the binding site pockets (active site) of 6LU7 are listed in Table 1 . The results of molecular docking are displayed in Fig. 2 . The binding affinity (∆G) of (drug) compounds depends on the type of bonding (H-bond) that occurs with the active site of the protein. 18 ) and aloenin (∆G = -9.13), respectively. This also provides us an opportunity to compare the ∆G value of the compounds extracted from other plants. Fig. 3 plots the binding affinities of these compounds, along with those of a few previously reported inhibitors such as remdesivir, chloroquine and hydroxychloroquine. Considering hydroxychloroquine as a reference, we note that the inhibition potentials of the extracts of harsingar, aloe vera and giloy are very encouraging. The extracts of turmeric, neem, ashwagandha and ginger have larger inhibition potentials than that of chloroquine. The compounds extracted from other plants also possess certain inhibition properties against COVID-19 protease. We have performed an in silico study on the inhibition of COVID-19 protease by the extracts of Indian herbal plants. We noticed that all these plants possess inhibition properties to a certain extent. Based on the binding affinity as well as log P and log S values, harsingar, aloe vera and giloy appear as the most powerful inhibitors among the eleven plants considered here. Other potential inhibitors of COVID-19 protease include turmeric, neem, ashwagandha and ginger. The inhibition potentials of all these plant extracts are found to be larger than those of chloroquine and hydroxychloroquine. These two anti-malarial drug compounds are already reported to inhibit COVID-19 protease in vitro. Due to inherent toxicity and side-effects, however, they are not approved by most of the countries. Therefore, our findings become very interesting towards the development of alternative (herbal) medicines having no apparent sideeffects. We expect prompt actions in this direction to combat with the COVID-19. A pneumonia outbreak associated with a new coronavirus of probable bat origin A new coronavirus associated with human respiratory disease in China The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Therapeutic options for the 2019 novel coronavirus Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV IMPPAT: A curated database of Indian Medicinal Plants Current status of herbal and their future perspectives Indian Medicinal Plants: An Illustrated Dictionary SwissDock, a protein-small molecule docking web service based on EADock DSS Fast docking using the CHARMM force field with EADock DSS UCSF Chimera -a visualization system for exploratory research and analysis Neural network modeling for estimation of partition coefficient based on atom-type electrotopological state indices Internet software for the calculation of the lipophilicity and aqueous solubility of chemical compounds Prediction of drug solubility from Monte Carlo simulations